Introduction
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders that impair cortisol biosynthesis. In 95% of cases it is caused by mutations in CYP21A2, the gene encoding the adrenal steroid 21-hydroxylase enzyme. 1 Deficiency of 21-hydroxylase leads to an accumulation of cortisol precursors that get diverted to sex hormone biosynthesis. Consequently there is a wide range of clinical features including adrenal insufficiency, genital ambiguity, infertility, short stature, hypertension and an increased risk of metabolic syndrome. 2 21-hydroxylase deficiency is classified into 3 subtypes according to clinical severity: classic salt-wasting, classic simple virilising, and nonclassic CAH (mild/late onset). 1 Non-classic CAH is one of the most common autosomal recessive disorders in humans and affects approximately 1 in 1,000 individuals. 3
Case Presentation
We present the case of a 28-year old woman, who presented with menstrual irregularity and hirsutism since menarche, at age 11. She had been treated with the oral contraceptive pill (Dianettte) for 12 years, in the context of a diagnosis of polycystic ovarian syndrome, despite BMI of 21 kg/m 2 .
Investigations
Blood pressure was 101/66mmHg. Baseline electrolytes showed sodium 140mmol/L, potassium 3.6mmol/L. Testosterone level was 2.1 nmol/L. Short and long synachthen tests confirmed the biochemical diagnosis of CAH (Table 1 and 2). Prolonged oral glucose tolerance test was performed (Table 3) , as she complained of hypoglycaemia-like symptoms, confirming hypoglycaemia at 3 hours post-glucose load (glucose 2.1mmol/L) with appropriate spontaneous recovery (glucose 4.1 mmol/L at 300min). Genetic testing confirmed non-classical CAH due to 21-hydroxylase deficiency. She was heterozygous for c.89C>T and c.841G>T with normal CYP21A2 copy number.
Discussion
Non-classic CYP21A2 deficiency is one of the most common autosomal recessive diseases. Non-classic CAH and polycystic ovarian syndrome may present similarly as hirsutism is the single most common symptom in patients with non-classic CAH followed by oligomenorrhea and acne. 4 Despite general correlations, the CYP21A2 deficiency phenotype does not always correlate precisely with the genotype, suggesting that other genes influence the clinical manifestations. Women with late-onset form may be compound heterozygotes (classic mutation and a variant allele) or heterozygotes with two variant alleles, allowing for 20-60% of normal enzymatic activity. 4 This leads to observation of a wide range of phenotypes. Women who are compound heterozygotes for two different CYP21A2 mutations usually have the phenotype associated with the less severe of the two genetic defects. 
Follow up
She started Dexamethasone 0.25 mg daily and responded well. Androstenedione levels decreased to 11.4nmol/L. She is still complaining of fatigue in early evening and a cortisol day curve is scheduled to investigate need for a second dose of dexamethasone. 
